Global epidemiology of viral hepatitis and national needs for complete control-Reference-Cited by-同舟云学术

Global epidemiology of viral hepatitis and national needs for complete control

Published:2018-08-02 Issue:8 Volume:16 Page:625-639
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Lanini Simone¹,Pisapia Raffaella¹,Capobianchi Maria Rosaria¹,Ippolito Giuseppe¹

Affiliation:

1. Dipartimento Epidemiologia, Ricerca Preclinica e Diagnostica Avanzata, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy

Funder

Ministero della Salute

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2018.1505503

Reference119 articles.

1. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Available at http://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf?sequence=1; accessed 2018 Jul 17.

2. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention

3. Epidemiology and Genetic Characterization of Hepatitis A Virus Genotype IIA

4. Hepatitis A virus: Host interactions, molecular epidemiology and evolution

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Schisandrae Fructus alone or in combination in viral hepatitis treatment: A systematic review and meta-analysis of randomized controlled trials;Science of Traditional Chinese Medicine;2024-09-04

2. Trend analysis of hepatitis B and C among patients visiting health facility of Tigrai, Ethiopia, 2014–2019;BMC Gastroenterology;2023-05-19

3. MicroRNAs in Liver Disease;MicroRNA in Regenerative Medicine;2023

4. Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries;Microorganisms;2022-10-22

5. Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1–Induced OCT4/Nanog Pathway;The Journal of Immunology;2022-02-01